Wed, May 14, 8:19 PM (66 days ago)
**Archimedes Tech SPAC Partners II Co. (ATIIU) Q1 2025 Financial Summary** **Financial Health & Performance Metrics:** - **Revenue:** No operational revenue generated; non-operating income from interest on trust account funds. - **Profit Margins:** Net income of $1,159,223, primarily from interest earned on cash held in the trust account. - **Cash Flow:** Net cash used in operating activities was $254,007; significant cash inflows from financing activities totaling $233,267,180. - **Earnings Changes:** No comparative earnings data for Q1 2024 as the company was not operational. **Quarterly Performance Discussion:** - **Initial Public Offering (IPO):** Completed on February 12, 2025, raising $230,000,000 from 23,000,000 units, including the full exercise of the underwriters' over-allotment option. - **Private Placement:** Simultaneously, 840,000 private placement units were sold, generating $8,400,000. - **Trust Account:** $231,150,000 placed in a trust account, invested in U.S. government treasury obligations. - **Expenses:** General and administrative expenses amounted to $146,661. **Trends & Uncertainties:** - **Geopolitical Risks:** Global market volatility due to ongoing conflicts and sanctions. - **Business Combination:** The company has until 21 months from the IPO to complete a business combination. - **Redemption Risks:** Shareholders have the right to redeem their shares if the company does not complete a business combination within the specified timeframe. **Future Operations Impact:** - **Fund Utilization:** Substantially all funds in the trust account will be used for the business combination. - **Working Capital:** Funds held outside the trust account will be used for identifying and evaluating target businesses. - **Liquidity:** The company may need additional financing if the actual costs of identifying a target business exceed estimates. **Ticker:** ATIIU **Full Name:** Archimedes Tech SPAC Partners II Co.